Pathology Imaging Systems Market Report 2026

Pathology Imaging Systems Market Overview

• Pathology Imaging Systems market size has reached to $1.37 billion in 2025 • Expected to grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Expansion Of Clinical Trials Activities Driving The Market Growth Due To Rising Demand For Advanced Diagnostic Imaging Tools • Market Trend: Artificial Intelligence (AI)-Powered Quality Control Solutions Improve Workflow Efficiency And Diagnostic Accuracy In Pathology Imaging Systems • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Pathology Imaging Systems Market?

The pathology imaging systems refer to advanced digital imaging platforms and equipment designed to capture, store, analyze, and share high-resolution images of tissue samples and laboratory specimens for diagnostic applications. These systems improve the accuracy and speed of disease diagnosis, particularly for cancer and chronic conditions, through digital pathology and AI-assisted analysis. The main components of pathology imaging systems include hardware, software, and services. Hardware refers to advanced imaging devices used to capture, process, and analyze high-resolution digital pathology images for diagnostic and research purposes. These systems are based on technologies such as artificial intelligence based systems, machine learning enabled systems, and conventional digital imaging systems and are deployed through on premise and cloud based models. They are used across applications including academic research and clinical diagnosis, serving end users such as hospitals, diagnostic laboratories, and research organizations.

What Is The Pathology Imaging Systems Market Growth Forecast?

The pathology imaging systems market size is expected to see rapid growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to Ai-assisted diagnostic adoption, cloud-based pathology platforms expansion, rising demand for precision medicine, growth in remote diagnostic services, integration of hospital it and imaging ecosystems. Major trends in the forecast period include increasing adoption of telepathology and remote diagnostic outsourcing models, rising demand for whole slide imaging standardization and interoperability, expansion of centralized pathology laboratories across multi-hospital networks, growing regulatory focus on digital pathology validation and diagnostic accuracy standards, increased integration of laboratory information systems with imaging workflows.

Global Pathology Imaging Systems Market Segmentation

1) By Component: Hardware, Software, Services 2) By Technology: Artificial Intelligence Based Systems, Machine Learning Enabled Systems, Conventional Digital Imaging Systems 3) By Deployment Mode: On Premise, Cloud Based 4) By Application: Academic Research, Clinical Diagnosis 5) By End Users: Hospitals, Diagnostic Laboratories, Research Organizations Subsegments: 1) By Hardware: Imaging Devices, Scanning Systems, Digital Cameras, Microscopes, Display Systems 2) By Software: Image Analysis Software, Data Management Software, Workflow Management Software, Diagnostic Software, Visualization Software 3) By Services: Installation Services, Maintenance Services, Training Services, Consulting Services, Technical Support Services

What Is The Driver Of The Pathology Imaging Systems Market?

The expansion of clinical trial activities is expected to propel the growth of the pathology imaging systems market going forward. Clinical trial activities refer to the systematic process of conducting research studies on human participants to evaluate the safety and efficacy of new drugs, therapies, medical devices, and diagnostic tools. The growing volume of clinical trials is largely driven by increased pharmaceutical and biotechnology research and development investments, as companies and government agencies accelerate the discovery of new treatments across a wide range of diseases. This surge in clinical trial activity boosts demand for pathology imaging systems, as these systems are critical for accurate tissue analysis, biomarker identification, and real-time monitoring of patient outcomes within research settings. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the count of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the expansion of clinical trial activities is driving the growth of the pathology imaging systems industry.

Key Players In The Global Pathology Imaging Systems Market

Major companies operating in the pathology imaging systems market are F. Hoffmann-La Roche AG, FUJIFILM Corporation, Philips Healthcare, GE HealthCare Technologies Inc., Agilent Technologies Inc., Olympus Corporation, Carl Zeiss Meditec AG, Hamamatsu Photonics K.K., Huron Technologies International Inc., Leica Biosystems Nussloch GmbH, Motic Xiamen Medical Diagnostic Systems Co. Ltd., Sectra AB, Sakura Finetek Japan Co. Ltd., Akoya Biosciences Inc., OptraSCAN Inc., Visiopharm A/S, Indica Labs LLC, SPOT Imaging, Objective Imaging Ltd., Corista LLC, Glencoe Software Inc., Paige.ai, PathAI, Proscia, Ibex Medical Analytics, Tribun Health

Global Pathology Imaging Systems Market Trends and Insights

Major companies operating in the pathology imaging systems market are focusing on developing advanced solutions, such as AI-powered quality control software, to enhance image consistency, reduce manual intervention, and improve laboratory workflow efficiency. AI-powered quality control software refers to intelligent imaging technology that automatically detects scanning artifacts and image quality issues during slide digitization, helping laboratories minimize rework and improve diagnostic precision. For instance, in March 2026, Leica Biosystems, a US-based provider of anatomic and digital pathology solutions, launched the Aperio GT Elite scanner along with Aperio iQC software. The solution integrates AI-powered quality control directly into the digital pathology workflow, enabling automatic detection of whole-slide imaging artifacts while slides remain on the scanner. The system offers high-throughput slide processing, barcode-driven automation, and faster quality control review, supporting improved laboratory efficiency, workflow standardization, and enhanced pathology imaging performance.

What Are Latest Mergers And Acquisitions In The Pathology Imaging Systems Market?

In June 2024, Quest Diagnostics, a US-based provider of diagnostic information services and laboratory testing solutions, acquired PathAI Diagnostics' lab assets from PathAI for an undisclosed amount. With this acquisition, Quest Diagnostics aims to accelerate the adoption of artificial intelligence and digital pathology technologies to enhance cancer diagnosis and improve diagnostic efficiency across its pathology network. PathAI is a US-based provider of AI-powered digital pathology solutions, including advanced imaging, data analysis, and diagnostic support services for pathology laboratories and biopharmaceutical companies.

Regional Outlook

North America was the largest region in the pathology imaging systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period.The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pathology Imaging Systems Market?

The pathology imaging systems market consists of revenues earned by entities by providing services such as digital pathology services, image analysis services, cloud-based pathology data management services, telepathology services, system integration services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pathology imaging systems market also includes sales of slide scanners, digital microscopes, AI-based diagnostic tools, storage systems, servers, display systems, and laboratory information systems (LIS) integration tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pathology Imaging Systems Market Report 2026?

The pathology imaging systems market research report is one of a series of new reports from The Business Research Company that provides pathology imaging systems market statistics, including pathology imaging systems industry global market size, regional shares, competitors with a pathology imaging systems market share, detailed pathology imaging systems market segments, market trends and opportunities, and any further data you may need to thrive in the pathology imaging systems industry. This pathology imaging systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.